|
|
||||||||
1 Laboratory of Medical Microbiology, University of Antwerp, Belgium
2 Department of Fundamental Microbiology, University of Lausanne, Switzerland
3 Laboratory of Microbiology, Ghent University, Ghent, Belgium
4 BCCM/LMG Bacteria Collection, Ghent University, Ghent, Belgium
5 LUMC, Department of Medical Microbiology, Leiden, The Netherlands
Correspondence
José M. Entenza
jose.entenza{at}unil.ch
Received 6 September 2006
Accepted 16 April 2007
108 c.f.u.). All isolates had comparable bacterial counts in cardiac vegetations (P>0.05). Except for one L. paracasei strain adhering to all substrates, all tested lactobacilli adhered only weakly or not at all. The platelet peptide FP-A did not show any microbicidal activity against the tested lactobacilli, whereas CTAP-3 killed the majority of the isolates. In general, these results indicate that probiotic lactobacilli display a lower infectivity in experimental endocarditis compared with true endocarditis pathogens. However, the difference in infectivity between L. rhamnosus endocarditis and (potentially) probiotic isolates could not be explained by differences in adherence or platelet microbicidal protein susceptibility. Other disease-promoting factors may exist in these organisms and warrant further investigation.
Abbreviations: FAFLP, fluorescent amplified fragment length polymorphism; ID90, 90 % infective dose.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |